2025-07-16 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the data you provided. The report is written in English and includes numerical data and corresponding analysis.

**Report: Albemarle Corp (ALB) Analysis**

**Company Overview:** Albemarle Corp is a specialty chemicals company with leading positions in lithium, bromine specialties, and catalysts.

**1. Performance vs. S&P 500 (VOO)**

*   **ALB Cumulative Return:** 16.34%
*   **VOO Cumulative Return:** 95.00%
*   **Deviation:** -72.7
*   **Relative Deviation:** 4.3

**Analysis:** ALB has significantly underperformed the S&P 500 (VOO). The current deviation is -72.7, placing it near the lower end of its historical deviation range (4.3 relative deviation).

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| :----------- | :------ | :------ | :------ | :---- | :----- |
| 2015-2017  | 99.0%   | 8.1%    | 70.0%   | 0.0   | 15.1   |
| 2016-2018  | 13.0%   | 58.0%   | -5.0%   | 0.0   | 9.1    |
| 2017-2019  | -44.0%  | 58.0%   | -74.0%  | -0.0  | 8.6    |
| 2018-2020  | 101.0%  | 62.9%   | 81.0%   | 0.6   | 17.4   |
| 2019-2021  | 268.0%  | 62.9%   | 220.0%  | 0.6   | 27.5   |
| 2020-2022  | 239.0%  | 75.6%   | 237.0%  | 0.8   | 25.5   |
| 2021-2023  | -53.0%  | 77.5%   | -71.0%  | 0.6   | 17.0   |
| 2022-2024  | -200.0% | 77.5%   | -225.0% | 0.7   | 10.1   |
| 2023-2025  | -332.0% | 77.5%   | -379.0% | 3.0   | 8.2    |

**Analysis:**

*   **CAGR & MDD:** The CAGR (Compound Annual Growth Rate) fluctuates significantly, with strong positive periods followed by substantial negative periods. The MDD (Maximum Drawdown) is consistently high, indicating significant volatility.
*   **Alpha:** The Alpha values ​​are highly variable, suggesting that ALB's performance deviates significantly from its expected return based on its beta. Negative alphas indicate underperformance compared to its risk-adjusted expected return.
*   **Beta:** Beta values have fluctuated from around 0 to 0.8, increasing to 3 recently, suggesting the stock's sensitivity to market movements has recently increased.
*   **Cap:** Market capitalization increased significantly from 2015 to 2022, but decreased later.

**2. Recent Stock Price Movement**

*   **Current Price:** 69.99
*   **Last Market Data:** Price: 70.13, Previous Close: 70.00, Change: 0.18
*   **5-Day Moving Average:** 71.58
*   **20-Day Moving Average:** 64.89
*   **60-Day Moving Average:** 60.73

**Analysis:** The price is currently below the 5-day moving average, but above the 20-day and 60-day moving averages. The small price change indicates that market is stable.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.341 (Low Risk)
*   **RSI:** 66.98
*   **PPO:** 0.96
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Deviation Change:** 2.5 (+) (Short-term increase)
*   **Expected Return:** 2731.5% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** The MRI indicates "Low Risk."
*   **RSI:** An RSI of 66.98 suggests the stock is approaching overbought conditions but not yet in that territory.
*   **PPO:** A PPO of 0.96 suggests that the short-term moving average is slightly above the long-term moving average, indicating a potential upward trend.
*   **Hybrid Signal:** The signal suggests a cautious buy, indicating a small position should be taken.
*   **Recent Delta:** The recent increase in relative deviation suggests a short-term upward trend, but this needs to be viewed in the context of overall underperformance.
*   **Expected Return:** The extremely high expected return suggests a potentially very optimistic long-term outlook relative to the S&P 500, but should be viewed with skepticism.

**4. Recent News & Significant Events**

*   **2025-07-16:** Major business developments, regulatory changes, or market events.
*   **2025-07-13:** Analyst discussions on recent performance and outlook.
*   **2025-07-14:** Stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-07-15:** Market experts highlight both risks and opportunities.

**Analysis:** The news snippets suggest that Albemarle is experiencing significant activity, including volatility and scrutiny from analysts. Keeping abreast of specific news and company announcements is crucial.

**5. Recent Earnings Analysis**

| Date       | EPS   | Revenue   |
| :---------- | :---- | :-------- |
| 2025-04-30 | 0     | 1.08 B$   |
| 2024-11-06 | -9.45 | 1.35 B$   |
| 2024-07-31 | -1.96 | 1.43 B$   |
| 2024-05-01 | -0.08 | 1.36 B$   |
| 2025-04-30 | -0.08 | 1.36 B$   |

**Analysis:** The recent earnings data is concerning. EPS (Earnings Per Share) is negative for most quarters, and has been unstable recently. While revenue has been generally around $1.3B - $1.4B, it has decreased sharply recently.

**6. Financial Information**

**Revenue and Profitability**

| Quarter      | Revenue   | Profit Margin |
| :------------- | :-------- | :------------ |
| 2025-03-31   | $1.08B   | 14.51%        |
| 2024-12-31   | $1.23B   | 11.22%        |
| 2024-09-30   | $1.35B   | -7.68%        |
| 2024-06-30   | $1.43B   | -0.74%        |
| 2024-03-31   | $1.36B   | 2.86%        |

**Capital and Profitability**

| Quarter      | Equity    | ROE       |
| :------------- | :-------- | :-------- |
| 2025-03-31   | $10.03B   | 0.41%     |
| 2024-12-31   | $9.96B   | 0.76%     |
| 2024-09-30   | $10.24B   | -10.44%   |
| 2024-06-30   | $11.22B   | -1.68%    |
| 2024-03-31   | $11.53B   | 0.02%     |

**Analysis:**

*   **Revenue:** Revenue has declined in the most recent quarters.
*   **Profit Margin:** Profit margins have been volatile, with negative margins in two of the last five quarters. This is a major concern.
*   **Equity:** Equity has also decreased over the period.
*   **ROE:** Return on Equity (ROE) is also very volatile and has been mostly near 0% or negative.

**7. Overall Analysis**

Albemarle (ALB) has significantly underperformed the S&P 500. Recent earnings and financial data reveal declining revenue, volatile and often negative profit margins, and decreasing equity. The technical indicators present a mixed picture, with a low-risk MRI, but an RSI approaching overbought territory. News reports indicate significant market activity and analyst scrutiny.  The extremely high "expected return" should be taken with extreme caution.

**Recommendation:**

Given the underperformance relative to the market, declining financial performance, and volatile profit margins, a cautious approach to ALB is warranted. Investors should carefully monitor upcoming earnings reports, news, and industry developments. The Hybrid Signal's "cautious buy" recommendation reflects the uncertainty surrounding the stock. Further research into the reasons behind the declining profitability and revenue is strongly recommended before making any investment decisions.
